CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins

International Journal of Cell Biology

Volumn 2014, Issue , 2014, Pages

  Dehghani, Mehdi ^a,b   Kianpour, Sedigheh ^a   Zangeneh, Ana ^c   Mostafavi Pour, Zohreh ^a,d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; FIBRONECTIN; FOCAL ADHESION KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SHC; PROTEIN TYROSINE PHOSPHATASE SHP 2; STROMAL CELL DERIVED FACTOR 1; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5; VINCULIN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GLEASON SCORE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 84926351192     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2014/981750     Document Type: Article

References (48)

1. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2013," CA Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11-30, 2013.
2. Y.-X. Sun, J. Wang, C. E. Shelburne et al., "Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo," Journal of Cellular Biochemistry, vol. 89, no. 3, pp. 462-473, 2003.
3. G. Chodak, "Prostate cancer: epidemiology, screening, and biomarkers," Reviews in Urology, vol. 8, supplement 2, pp. S3-S8, 2006.
4. J. D. Hood and D. A. Cheresh, "Role of integrins in cell invasion and migration," Nature Reviews Cancer, vol. 2, no. 2, pp. 91-100, 2002.
5. W. Guo and F. G. Giancotti, "Integrin signalling during tumour progression," Nature Reviews Molecular Cell Biology, vol. 5, no. 10, pp. 816-826, 2004.
6. C. L. Hall, C. W. Dubyk, T. A. Riesenberger, D. Shein, E. T. Keller, and K. L. van Golen, "Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RhoC GTPase," Neoplasia, vol. 10, no. 8, pp. 797-803, 2008.
7. A. Moroz, F. K. Delella, L. M. Lacorte, E. Deffune, and S. L. Felisbino, "Fibronectin induces MMP2 expression in human prostate cancer cells," Biochemical and Biophysical Research Communications, vol. 430, no. 4, pp. 1319-1321, 2013.
8. S. K. Akiyama, K. Olden, and M. Yamada, "Fibronectin and integrins in invasion and metastasis," Cancer and Metastasis Reviews, vol. 14, no. 3, pp. 173-189, 1995.
9. P. A. Torzilli, J. W. Bourne, T. Cigler, and C. T. Vincent, "A new paradigm for mechanobiological mechanisms in tumor metastasis," Seminars in Cancer Biology, vol. 22, no. 5-6, pp. 385-395, 2012.
10. S. Singh, U.P. Singh, W.E. Grizzle, and J.W. Lillard Jr., "CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion," Laboratory Investigation, vol. 84, no. 12, pp. 1666-1676, 2004.
11. J. Vandercappellen, J. van Damme, and S. Struyf, "The role of CXC chemokines and their receptors in cancer," Cancer Letters, vol. 267, no. 2, pp. 226-244, 2008.
12. B. A. Teicher and S. P. Fricker, "CXCL12 (SDF-1)/CXCR4 pathway in cancer," Clinical Cancer Research, vol. 16, no. 11, pp. 2927-2931, 2010.
13. J. Jones, D. Marian, E. Weich et al., "CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells," Experimental Cell Research, vol. 313, no. 19, pp. 4051-4065, 2007.
14. J. Wang, R. Loberg, and R. S. Taichman, "The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis," Cancer and Metastasis Reviews, vol. 25, no. 4, pp. 573-587, 2006.
15. R. S. Taichman, C. Cooper, E. T. Keller, K. J. Pienta, N. S. Taichman, and L. K. McCauley, "Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone," Cancer Research, vol. 62, no. 6, pp. 1832-1837, 2002.
16. M. J. Humphries, "Cell Adhesion Assays," in Extracellular Matrix Protocols, pp. 1-8, 2009.
17. Z. Mostafavi-Pour, J. A. Askari, S. J. Parkinson, P. J. Parker, T. T. C. Ng, and M. J. Humphries, "Integrin-specific signaling pathways controlling focal adhesion formation and cell migration," The Journal of Cell Biology, vol. 161, no. 1, pp. 155-167, 2003.
18. M. Adachi, T. Taki, M. Higashiyama, N. Kohno, H. Inufusa, and M. Miyake, "Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer," Clinical Cancer Research, vol. 6, no. 1, pp. 96-101, 2000.
19. K. M. Kirschner, N. Wagner, K.-D. Wagner, S. Wellmann, and H. Scholz, "The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the α4integrin gene," The Journal of Biological Chemistry, vol. 281, no. 42, pp. 31930-31939, 2006.
20. A. Müller, B. Homey, H. Soto et al., "Involvement of chemokine receptors in breast cancer metastasis," Nature, vol. 410, no. 6824, pp. 50-56, 2001.
21. S. M. Potter, R. M. Dwyer, C. E. Curran et al., "Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones," Breast Cancer Research and Treatment, vol. 115, no. 2, pp. 279-287, 2009.
22. J. R. Stark, S. Perner, M. J. Stampfer et al., "Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?" Journal of Clinical Oncology, vol. 27, no. 21, pp. 3459-3464, 2009.
23. J. A. Macoska, L. A. Begley, R. L. Dunn, J. Siddiqui, J. T. Wei, and A. V. Sarma, "Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA," Prostate, vol. 68, no. 4, pp. 442-452, 2008.
24. S. R. Chinni, S. Sivalogan, Z. Dong et al., "CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12," Prostate, vol. 66, no. 1, pp. 32-48, 2006.
25. Y.-X. Sun, M. Fang, J. Wang, C. R. Cooper, K. J. Pienta, and R. S. Taichman, "Expression and activation of αvβ3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells," Prostate, vol. 67, no. 1, pp. 61-73, 2007.
26. T. Engl, B. Relja, D. Marian et al., "CXCR4 chemokine receptor mediates prostate tumor cell adhesion through α5 and β3 integrins," Neoplasia, vol. 8, no. 4, pp. 290-301, 2006.
27. K. Chu, C.-J. Cheng, X. Ye et al., "Cadherin-11 promotes the metastasis of prostate cancer cells to bone," Molecular Cancer Research, vol. 6, no. 8, pp. 1259-1267, 2008.
28. J.D. Humphries, P. Wang, C. Streuli, B. Geiger, M. J. Humphries, and C. Ballestrem, "Vinculin controls focal adhesion formation by direct interactions with talin and actin," Journal of Cell Biology, vol. 179, no. 5, pp. 1043-1057, 2007.
29. H.-S. Lee, P. Anekal, C. J. Lim, C.-C. Liu, and M. H. Ginsberg, "Two modes of integrin activation form a binary molecular switch in adhesion maturation," Molecular Biology of the Cell, vol. 24, no. 9, pp. 1354-1362, 2013.
30. V. M. Golubovskaya, F. A. Kwen, and W. G. Cance, "Focal adhesion kinase and cancer," Histology and Histopathology, vol. 24, no. 4, pp. 503-510, 2009.
31. D. Docheva, D. Padula, M. Schieker, and H. Clausen-Schaumann, "Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells," Biochemical and Biophysical Research Communications, vol. 402, no. 2, pp. 361-366, 2010.
32. C. L. Hall, J. Dai, K. L. van Golen, E. T. Keller, and M.W. Long, "Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone," Cancer Research, vol. 66, no. 17, pp. 8648-8654, 2006.
33. Z. Lu, G. Jiang, P. Blume-Jensen, and T. Hunter, "Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase," Molecular and Cellular Biology, vol. 21, no. 12, pp. 4016-4031, 2001.
34. S. Zhang, L. Qi, M. Li et al., "Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer," Journal of Experimental and Clinical Cancer Research, vol. 27, article 62, 2008.
35. Y. Xing, M. Liu, Y. Du et al., "Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: a possible metastasis preventing and minimizing approach," Cancer Biology & Therapy, vol. 7, no. 11, pp. 1839-1848, 2008.
36. C.H. Tang, T. W. Tan, W. M. Fu, and R. S. Yang, "Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis," Carcinogenesis, vol. 29, no. 1, pp. 35-43, 2008.
37. Y.-C. Huang, Y.-C. Hsiao, Y.-J. Chen, Y.-Y. Wei, T.-H. Lai, and C.-H. Tang, "Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NFkappaB-dependent pathway in human lung cancer cells," Biochemical Pharmacology, vol. 74, no. 12, pp. 1702-1712, 2007.
38. T.N. Hartmann, J. A. Burger, A. Glodek, N. Fujii, and M. Burger, "CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells," Oncogene, vol. 24, no. 27, pp. 4462-4471, 2005.
39. C. H. Streulli and N. Akhtar, "Signal co-operation between integrins and other receptor systems," Biochemical Journal, vol. 418, no. 3, pp. 491-506, 2009.
40. J. Zhao and J.-L. Guan, "Signal transduction by focal adhesion kinase in cancer," Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 35-49, 2009.
41. S. K. Mitra and D. D. Schlaepfer, "Integrin-regulated FAK-Src signaling in normal and cancer cells," Current Opinion in Cell Biology, vol. 18, no. 5, pp. 516-523, 2006.
42. S. K. Mitra, D. A. Hanson, and D.D. Schlaepfer, "Focal adhesion kinase: in command and control of cellmotility," Nature Reviews Molecular Cell Biology, vol. 6, no. 1, pp. 56-68, 2005.
43. H. L. Goel, N. Alam, I. N. S. Johnson, and L. R. Languino, "Integrin signaling aberrations in prostate cancer," American Journal of Translational Research, vol. 1, no. 3, pp. 211-220, 2009.
44. Q. Shi and D. Boettiger, "A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397," Molecular Biology of the Cell, vol. 14, no. 10, pp. 4306-4315, 2003.
45. G. J. Mizejewski, "Role of integrins in cancer: survey of expression patterns," Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 2, pp. 124-138, 1999.
46. H. L. Goel, J. Li, S. Kogan, and L. R. Languino, "Integrins in prostate cancer progression," Endocrine-Related Cancer, vol. 15, no. 3, pp. 657-664, 2008.
47. K.-O. Uhm, J. O. Lee, Y. M. Lee, E. S. Lee, H. S. Kim, and S.-H. Park, "Aberrant DNA methylation of integrin α4: a potential novel role for metastasis of cholangio carcinoma," Journal of Cancer Research and Clinical Oncology, vol. 136, no. 2, pp. 187-194, 2010.
48. J. Park, S. H. Song, T. Y. Kim et al., "Aberrant methylation of integrin α4 gene in human gastric cancer cells," Oncogene, vol. 23, no. 19, pp. 3474-3480, 2004.